For the Treatment of Multiple Sclerosis, More Than 85 Percent of Surveyed Neurologists in the EU5 Expect to Prescribe Biogen Idec`s BG-12, Sanofi/Genzyme`s Aubagio and Sanofi/Genyzme/Bayer Healthcare`s Lemtrada